1-109923697-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_000757.6(CSF1):c.1076C>T(p.Pro359Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,613,402 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_000757.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSF1 | NM_000757.6 | c.1076C>T | p.Pro359Leu | missense_variant | 6/9 | ENST00000329608.11 | NP_000748.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSF1 | ENST00000329608.11 | c.1076C>T | p.Pro359Leu | missense_variant | 6/9 | 1 | NM_000757.6 | ENSP00000327513.6 | ||
CSF1 | ENST00000369802.7 | c.1076C>T | p.Pro359Leu | missense_variant | 6/9 | 1 | ENSP00000358817.3 | |||
CSF1 | ENST00000369801.1 | c.1076C>T | p.Pro359Leu | missense_variant | 6/9 | 1 | ENSP00000358816.1 | |||
CSF1 | ENST00000420111.6 | c.545-363C>T | intron_variant | 5 | ENSP00000407317.2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250628Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135436
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461184Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 726792
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74362
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at